Pulmonary Fibrosis After COVID-19: Treatments and Transplant
ABOUT THIS EPISODE
Originally aired: October 28, 2021
Hear from pulmonologists about the outlook of post-COVID chronic lung disease, including a discussion of what we understand about the factors that contribute to the development of post-COVID fibrosis, the role of emerging therapies such as antifibrotics and antiinflammatory agents, and when to consider lung transplantation.
Moderator
Holly Keyt, MD, FCCP
Panelists
Anna Podolanczuk, MD, MS
Corey Kershaw, MD, FCCP
Harpreet Grewal, MD